Astera Labs, Inc. Cash & Equivalents 2021-2026 | ALAB
What is cash & equivalents?
Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.
What is Astera Labs, Inc.'s current cash & equivalents?
Astera Labs, Inc. (ALAB) annual cash & equivalents for 2025 was $167.7M, a 109.49% increase from 2024. Astera Labs, Inc. cash & equivalents for the quarter ending March 31, 2026 was $148.4M.
What was Astera Labs, Inc.'s cash & equivalents in 2024?
Astera Labs, Inc. annual cash & equivalents for 2024 was $80.0M, a 77.49% increase from 2023.
What was Astera Labs, Inc.'s cash & equivalents in 2023?
Astera Labs, Inc. annual cash & equivalents for 2023 was $45.1M, a 40.73% decline from 2022.
What is Astera Labs, Inc.'s 4-year cash & equivalents CAGR?
Astera Labs, Inc. cash & equivalents grew at a compound annual growth rate (CAGR) of 34.72% from FY2021 to FY2025, going from $50.9M to $167.7M over 4 years.
Year-over-year comparison from 10-K annual reports